Browsing Diğer Yayınlar Koleksiyonu by Author "Mebazaa, Alexandre"
Now showing items 1-9 of 9
-
Cardiohepatic interactions in heart failure
Yilmaz, Mehmet Birhan; Nikolaou, Maria; Mebazaa, Alexandre (TURKISH SOC CARDIOLOGY, 2013)… -
Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure
Mebazaa, Alexandre; Laterre, Pierre Francois; Russell, James A.; Bergmann, Andreas; Gattinoni, Luciano; Gayat, Etienne; Harhay, Michael O.; Hartmann, Oliver; Hein, Frauke; Kjolbye, Anne Louise; Legrand, Matthieu; Lewis, Roger J.; Marshall, John C.; Marx, Gernot; Radermacher, Peter; Schroedter, Mathias; Scigalla, Paul; Stough, Wendy Gattis; Struck, Joachim; Van den Berghe, Greet; Yilmaz, Mehmet Birhan; Angus, Derek C. (BMC, 2016)Substantial attention and resources have been directed to improving outcomes of patients with critical illnesses, in particular sepsis, but all recent clinical trials testing various interventions or strategies have failed ... -
Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future
Rossignol, Patrick; Legrand, Matthieu; Kosiborod, Mikhail; Hollenberg, Steven M.; Peacock, W. Frank; Emmett, Michael; Epstein, Murray; Kovesdy, Csaba P.; Yilmaz, Mehmet Birhan; Stough, Wendy Gattis; Gayat, Etienne; Pitt, Bertram; Zannad, Faiez; Mebazaa, Alexandre (ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 2016)Hyperkalemia is a common electrolyte disorder, especially in chronic kidney disease, diabetes mellitus, or heart failure. Hyperkalemia can lead to potentially fatal cardiac dysrhythmias, and it is associated with increased ... -
In vivo and in vitro evidence for pleiotropic effects of levosimendan in the intensive care setting
Yilmaz, Mehmet Birhan; Mebazaa, Alexandre (BIOMED CENTRAL LTD, 2011)Levosimendan, in addition to its inotropic properties, could have anti-inflammatory and anti-oxidative properties, and can potentially decrease the deleterious effects of reactive oxygen species on the tissues. In their ... -
Levosimendan: Molecular mechanisms and clinical implications Consensus of experts on the mechanisms of action of levosimendan
Papp, Zoltan; Edes, Istvan; Fruhwald, Sonja; De Hert, Stefan G.; Salmenpera, Markku; Leppikangas, Heli; Mebazaa, Alexandre; Landoni, Giovanni; Grossini, Elena; Caimmi, Philippe; Morelli, Andrea; Guarracino, Fabio; Schwinger, Robert H. G.; Meyer, Sven; Algotsson, Lars; Wikstrom, Bernt Gerhard; Jorgensen, Kirsten; Filippatos, Gerasimos; Parissis, John T.; Garcia Gonzalez, Martin J.; Parkhomenko, Alexander; Yilmaz, Mehmet Birhan; Kivikko, Matti; Pollesello, Piero; Follath, Ferenc (ELSEVIER IRELAND LTD, 2012)The molecular background of the Ca2+-sensitizing effect of levosimendan relates to its specific interaction with the Ca2+-sensor troponin C molecule in the cardiac myofilaments. Over the years, significant preclinical and ... -
Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Harjola, Veli-Pekka; Mullens, Wilfried; Banaszewski, Marek; Bauersachs, Johann; Brunner-La Rocca, Hans-Peter; Chioncel, Ovidiu; Collins, Sean P.; Doehner, Wolfram; Filippatos, Gerasimos S.; Flammer, Andreas J.; Fuhrmann, Valentin; Lainscak, Mitja; Lassus, Johan; Legrand, Matthieu; Masip, Josep; Mueller, Christian; Papp, Zoltan; Parissis, John; Platz, Elke; Rudiger, Alain; Ruschitzka, Frank; Schaefer, Andreas; Seferovic, Petar M.; Skouri, Hadi; Yilmaz, Mehmet Birhan; Mebazaa, Alexandre (WILEY, 2017)Organ injury and impairment are commonly observed in patients with acute heart failure (AHF), and congestion is an essential pathophysiological mechanism of impaired organ function. Congestion is the predominant clinical ... -
Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine
Mebazaa, Alexandre; Yilmaz, M. Birhan; Levy, Phillip; Ponikowski, Piotr; Peacock, W. Frank; Laribi, Said; Ristic, Arsen D.; Lambrinou, Ekaterini; Masip, Josep; Riley, Jillian P.; McDonagh, Theresa; Mueller, Christian; deFilippi, Christopher; Harjola, Veli-Pekka; Thiele, Holger; Piepoli, Massimo F.; Metra, Marco; Maggioni, Aldo; McMurray, John; Dickstein, Kenneth; Damman, Kevin; Seferovic, Petar M.; Ruschitzka, Frank; Leite-Moreira, Adelino F.; Bellou, Abdelouahab; Anker, Stefan D.; Filippatos, Gerasimos (WILEY, 2015)Acute heart failure is a fatal syndrome. Emergency physicians, cardiologists, intensivists, nurses and other health care providers have to cooperate to provide optimal benefit. However, many treatment decisions are ... -
Renal Effects of Levosimendan: A Consensus Report
Yilmaz, Mehmet B.; Grossini, Elena; Silva Cardoso, Jose C.; Edes, Istvan; Fedele, Francesco; Pollesello, Piero; Kivikko, Matti; Harjola, Veli-Pekka; Hasslacher, Julia; Mebazaa, Alexandre; Morelli, Andrea; le Noble, Jos; Oldner, Anders; Oulego Erroz, Ignacio; Parissis, John T.; Parkhomenko, Alexander; Poelzl, Gerhard; Rehberg, Sebastian; Ricksten, Sven-Erik; Rodriguez Fernandez, Luis M.; Salmenpera, Markku; Singer, Mervyn; Treskatsch, Sascha; Vrtovec, Bojan; Wikstrom, Gerhard (SPRINGER, 2013)Renal dysfunction is common in clinical settings in which cardiac function is compromised such as heart failure, cardiac surgery or sepsis, and is associated with high morbidity and mortality. Levosimendan is a calcium ... -
Searching for an ideal hemodynamic marker to predict short-term outcome in cardiogenic shock
Yilmaz, Mehmet Birhan; Mebazaa, Alexandre (BMC, 2009)Cardiogenic shock is a lethal condition. Physicians are searching for hemodynamic markers which could help risk-stratification of patients in this picture. Torgersen and coworkers present an hourly time integral of the ...